PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
AboutPricing
Drug ReportsDesmotabs
Desmotabs
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Plot placeholder
Mock data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
122 clinical trials
View more details
Plot placeholder
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
NocturiaD053158—R35.1—71141031
Nocturnal enuresisD053206—N39.44——3111327
EnuresisD004775—R32———6915
Urinary incontinenceD014549—R32———6713
HemorrhageD006470MP_0001914R581224312
Hemophilia aD006467EFO_0007267D6611—248
PolyuriaD011141—R35——1326
Diabetes insipidusD003919—E23.2———145
Hemostatic disordersD020141—————134
Surgical blood lossD016063—————123
Show 12 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HyponatremiaD007010—E87.1—12—24
Inappropriate adh syndromeD007177EFO_1000982E22.2—11—12
Renal colicD056844EFO_1001412N23——1—12
ColicD003085—R10.83——1—12
Neurogenic diabetes insipidusD020790————1—12
LeptospirosisD007922EFO_0007344A27—11——1
Diabetes mellitusD003920EFO_0000400E08-E13——1——1
PainD010146EFO_0003843R52——1——1
Obstructive sleep apneaD020181EFO_0003918G47.33——1——1
Chronic renal insufficiencyD051436—N18——1——1
Show 1 more
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Von willebrand diseasesD014842EFO_0003910D68.0—2——35
Pituitary acth hypersecretionD047748EFO_1001110E24.0—1——23
StrokeD020521EFO_0000712I63.911———2
Cerebral hemorrhageD002543———2———2
Cushing syndromeD003480EFO_0003099E24—1——12
Thrombotic thrombocytopenic purpuraD011697—M31.19—1———1
PurpuraD011693HP_0000979D69.2—1———1
Type 2 von willebrand diseaseD056728Orphanet_166081D68.02—1———1
ShockD012769—R57.1—1———1
EdemaD004487—R60.9—1———1
Show 6 more
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients———2————2
HypertensionD006973EFO_0000537I101————1
Pure autonomic failureD054970——1————1
DyspneaD004417—R06.01————1
TachycardiaD013610—R00.01————1
Prostatic neoplasmsD011471—C611————1
ThrombosisD013927——1————1
EmbolismD004617——1————1
AtherosclerosisD050197EFO_0003914I25.11————1
Intracranial arteriosclerosisD002537EFO_1000860I67.21————1
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Blood platelet disordersD001791——————22
MenorrhagiaD008595EFO_0003945N92.0————22
Wounds and injuriesD014947—T14.8————11
Craniocerebral traumaD006259—S00————11
HemodilutionD006438——————11
Hematologic diseasesD006402EFO_0005803D75.9————11
Pituitary neoplasmsD010911——————11
Drug-related side effects and adverse reactionsD064420—T88.7————11
Water-electrolyte imbalanceD014883——————11
HypernatremiaD006955—E87.0————11
Show 21 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Plot placeholder
Mock data
Subscribe for the real data
30 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use